SCHEDULE: Medicus Pharma Insider Discloses 4.8% Stake

Dr. Raza Bokhari and RBx Capital, LP have disclosed a combined beneficial ownership of 4.8% of Medicus Pharma Ltd.'s common shares.

Summary

• Dr. Raza Bokhari and RBx Capital, LP reported beneficial ownership of Medicus Pharma Ltd. common shares.
• Dr. Raza Bokhari beneficially owns 1,218,173 common shares, representing 4.8% of the class.
• This ownership includes 425,000 common shares underlying stock options exercisable within 60 days and 793,173 common shares held by RBx Capital, LP, an entity controlled by Dr. Bokhari.
• RBx Capital, LP directly owns 793,173 common shares, representing 3.2% of the class.
• The percentages are calculated based on 25,114,144 common shares reported outstanding by the Company as of December 22, 2025.

Sentiment

Score: 6

Explanation: The disclosure of a significant insider stake, including exercisable options, by a key individual like Dr. Raza Bokhari is generally viewed as a positive signal of confidence in the company's future, though the filing itself is purely factual and does not contain performance data.

Positives

• Significant beneficial ownership by Dr. Raza Bokhari, including exercisable options, indicates a vested interest in the company's performance.
• The disclosure of an insider's substantial stake can signal confidence in the company's future prospects.

Management Comments

• Dr. Raza Bokhari disclaims beneficial ownership of securities held by RBx Capital, LP except to the extent of his direct ownership.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant insider ownership, which can influence investor confidence and perception of management alignment.
• Management: Reinforces the vested interest of a key individual in the company's performance.

Key Dates

Recommendation

This Schedule 13G filing primarily provides transparency on beneficial ownership by Dr. Raza Bokhari and RBx Capital, LP. While the significant insider stake (4.8%) can be interpreted as a positive signal of confidence, the filing itself does not contain new operational or financial performance data to warrant a 'buy' or 'sell' recommendation. It confirms a substantial insider position, which is generally a neutral to slightly positive factor, suggesting a 'hold' until further operational or financial updates are available.

Keywords

Medicus Pharma, beneficial ownership, Schedule 13G, Raza Bokhari, RBx Capital, insider ownership, common shares, stock options